Works matching IS 13866346 AND DT 2022 AND VI 52 AND IP 8

Results: 9

Impact of antiviral therapy for disease progression and non‐invasive liver fibrosis index in patients with chronic hepatitis C: Markov chain model analysis.

Published in:

Hepatology Research, 2022, v. 52, n. 8, p. 665, doi. 10.1111/hepr.13794

By:

Kaneko, Shun;
Kurosaki, Masayuki;
Kurisu, Akemi;
Akita, Tomoyuki;
Tanaka, Junko;
Kanto, Tatsuya

Publication type:

Article

Liver imaging reporting and data with perfluorobutane microbubbles—Is there hope?

Published in:: Hepatology Research, 2022, v. 52, n. 8, p. 663, doi. 10.1111/hepr.13803
Publication type:: Article

Lean/normal‐weight metabolic dysfunction‐associated fatty liver disease is a risk factor for reflux esophagitis.

Published in:

Hepatology Research, 2022, v. 52, n. 8, p. 699, doi. 10.1111/hepr.13795

By:

Fukunaga, Shuhei;
Nakano, Dan;
Tsutsumi, Tsubasa;
Kawaguchi, Takumi;
Eslam, Mohammed;
Yoshinaga, Shinobu;
Abe, Hirohiko;
Nouno, Ryuichi;
Joh, Seiya;
Mitsuyama, Keiichi;
George, Jacob;
Torimura, Takuji

Publication type:

Article

Comparison of modified CEUS LI‐RADS with sonazoid and CT/MRI LI‐RADS for diagnosis of hepatocellular carcinoma.

Published in:

Hepatology Research, 2022, v. 52, n. 8, p. 730, doi. 10.1111/hepr.13793

By:

Sugimoto, Katsutoshi;
Saito, Kazuhiro;
Shirota, Natsuhiko;
Kamiyama, Naohisa;
Sakamaki, Kentaro;
Takahashi, Hiroshi;
Wada, Takuya;
Kakegawa, Tatsuya;
Tomita, Yusuke;
Abe, Masakazu;
Yoshimasu, Yu;
Takeuchi, Hirohito;
Itoi, Takao

Publication type:

Article

Comparison of thrombocytopenia between patients with non‐alcoholic fatty liver disease and those with hepatitis C virus‐related chronic liver disease.

Published in:

Hepatology Research, 2022, v. 52, n. 8, p. 677, doi. 10.1111/hepr.13791

By:

Kinoshita, Naohiko;
Shima, Toshihide;
Terasaki, Kei;
Oya, Hirohisa;
Katayama, Takayuki;
Matsumoto, Junko;
Mitsumoto, Yasuhide;
Mizuno, Masayuki;
Mizuno, Chiemi;
Hirohashi, Rina;
Sakai, Kyoko;
Okanoue, Takeshi

Publication type:

Article

High fatty liver index is an independent predictor of ischemic heart disease during a 10‐year period in a Japanese population.

Published in:

Hepatology Research, 2022, v. 52, n. 8, p. 687, doi. 10.1111/hepr.13790

By:

Mori, Kazuma;
Tanaka, Marenao;
Higashiura, Yukimura;
Hanawa, Nagisa;
Ohnishi, Hirofumi;
Furuhashi, Masato

Publication type:

Article

Chronic liver disease questionnaire to manage patients with chronic liver diseases.

Published in:

Hepatology Research, 2022, v. 52, n. 8, p. 712, doi. 10.1111/hepr.13774

By:

Tajiri, Kazuto;
Futsukaichi, Yuka Hayashi;
Murayama, Aiko;
Minemura, Masami;
Takahara, Terumi;
Yasuda, Ichiro

Publication type:

Article

Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma.

Published in:

Hepatology Research, 2022, v. 52, n. 8, p. 721, doi. 10.1111/hepr.13773

By:

Xiang, Yan‐Jun;
Wang, Kang;
Yu, Hong‐Ming;
Li, Xiao‐Wei;
Cheng, Yu‐Qiang;
Wang, Wei‐Jun;
Feng, Jin‐Kai;
Bo, Meng‐Han;
Qin, Ying‐Yi;
Zheng, Yi‐Tao;
Shan, Yun‐Feng;
Zhou, Li‐Ping;
Zhai, Jian;
Cheng, Shu‐Qun

Publication type:

Article

Issue Information.

Published in:: Hepatology Research, 2022, v. 52, n. 8, p. 661, doi. 10.1111/hepr.13659
Publication type:: Article